Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: Family physicians' attitudes toward benzodiazepine prescribing

Canadian Family Physician

Volumn 56, Issue 11, 2010, Pages

  Anthierens, Sibyl ^a,b   Pasteels, Inge ^a   Habraken, Hilde ^c   Steinberg, Pascale ^d   Declercq, Tom ^b   Christiaens, Thierry ^e  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Project Farmaka   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

ADULT; ANXIETY; ARTICLE; BELGIUM; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HUMAN; INSOMNIA; MALE; PHYSICIAN ATTITUDE; QUESTIONNAIRE; STRESS;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; ATTITUDE OF HEALTH PERSONNEL; BELGIUM; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUESTIONNAIRES; SLEEP INITIATION AND MAINTENANCE DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 78649374620     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Deans HG, Skinner P. Doctors' views on anxiety management in general practice. J R Soc Med 1992;85(2):83-6.
2. Van Rijswijk E, Borghuis M, van de Lisdonk E, Zitman F, van Weel C. Treatment of mental health problems in general practice: a survey of psychotropics prescribed and other treatment provided. Int J Clin Pharmacol Ther 2007;45(1):23-9.
3. Balter MB, Manheimer DI, Mellinger GD, Uhlenhuth EH. A cross-national comparison of anti-anxiety/sedative drug use. Curr Med Res Opin 1984;8(Suppl 4):5-20.
4. IMS Health. Verkoops-en voorschriftgegevens - verkregen op verzoek [sales and prescription data]. Brussels, Belgium: IMS Health; 2003. Available from: www.imshealth.com. Accessed 2008 Oct 1.
5. De Donder E. Psychoactieve medicatie: Cijfers in perspectief 1990-2002. Antwerp-Apeldoorn, The Netherlands: Garant; 2004.
6. Van Rijswijk E, Zandstra SM, van de Lisdonk EH, Zitman FG, van Weel C. Appropriateness of benzodiazepine prescribing in general practice. Int J Clin Pharmacol Ther 2005;43(8):411-2.
7. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;(420):55-64. (Pubitemid 38686197)
8. Zandstra SM, Furer JW, van de Lisdonk EH, van't Hof M, Bor JH, van Weel C, et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002;37(3):139-44.
9. Kassam A, Patten SB. Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians. Popul Health Metr 2006;4:15.
10. Van Hulten R, Isacson D, Bakker A, Leufkens HG. Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf 2003;12(1):49-53. (Pubitemid 36192949)
11. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162(2):225-33.
12. Buysse DJ, Reynolds CF. Pharmacologic treatment. In: Lichstein KL, Morin CM, editors. Treatment of late-life insomnia. Thousand Oaks, CA: Sage Publications; 2000. p. 231-67.
13. Martinez-Cano H, Vela-Bueno A, De Iceta M, Pomalima R, Martinez-Graz I, Paz Sobrino M. Benzodiazepine types in high versus therapeutic dose dependence. Addiction 1996;91(8):1179-86.
14. De las Cuevas C, Sanz E, de la Fuente J. Benzodiazepines: more "behavioural" addiction than dependence. Psychopharmacology (Berl) 2003;167(3):297-303. Epub 2003 Apr 1.
15. Hajak G, Clarenbach P, Fischer W, Rodenbeck A, Bandelow B, Broocks A, et al. Rebound insomnia after hypnotic withdrawal in insomniac outpatients. Eur Arch Psychiatry Clin Neurosci 1998;248(3):148-56. (Pubitemid 28396010)
16. Juergens SM. Problems with benzodiazepines in elderly patients. Mayo Clin Proc 1993;68(8):818-20.
17. Ashton H. Benzodiazepine abuse, drugs and dependence. New York, NY: Harwood Academic Publishers; 2002. p. 197-212.
18. Ten Wolde GB, Dijkstra A, Van Empelen P, Knuisting Neven A, Zitman FG. Social-cognitive predictors of intended and actual benzodiazepine cessation among chronic users. Addict Behav 2008;33(9):1091-103. Epub 2008 Feb 20.
19. Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. Sleep 2001;24(4):411-7.
20. Baillargeon L, Demers M, Ladouceur R. Stimulus control: nonpharmacologic treatment for insomnia. Can Fam Physician 1998;44:73-9.
21. Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther 2001;39(1):45-60.
22. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioural and pharmacological therapies for late-life insomnia: a randomised controlled trial. JAMA 1999;281(11):991-9.
23. Clark DM, Ehlers A, McManus F, Hackmann A, Fennel M, Campbell H, et al. Cognitive therapy versus fluoxetine: a randomised placebo-controlled trial. J Consult Clin Psychol 2003;71(6):1058-67.
24. Anthierens S, Habraken H, Petrovic M, Christiaens T. The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs, perspectives. Scand J Prim Health Care 2007;25(4):214-9. (Pubitemid 350179029)
25. Anthierens S, Habraken H, Petrovic M, Deveugele M, De Maeseneer J, Christiaens T. First benzodiazepine prescriptions: qualitative study of patients' perspectives. Can Fam Physician 2007;53:1200-1.e1-5. Available from: www.cfp.ca/cgi/reprint/53/7/1200. Accessed 2010 Oct 1.
26. NHG-standaard Slapeloosheid en. In: Geijer RMM, editor. NHG-standaarden voor de huisarts, deel I. 2e geh. herz. dr. Maarssen, The Netherlands: Elsevier, Bunge; 1999. p. 286-99.
27. Declercq T, Rogiers R, Habraken H, Michels J, Mariman A, De Meyere M. Insomnia in de eerste lijn. WVVH-aanbeveling voor goede medische praktijkvoering. Berchem, Belgium: Scientific Association of Flemish Family Physicians; 2004.
28. Bjørner T, Laerum E. Factors associated with high prescribing of benzodiazepines and minor opiates. A survey among general practitioners in Norway. Scand J Prim Health Care 2003;21(2):115-20. (Pubitemid 36773422)
29. Greenblatt DJ, Shader RI, Abernethy DR. Drug therapy: current status of benzodiazepines. N Engl J Med 1983;309(6):354-8.
30. Tinetti ME, Speechly M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319(26):1701-7.
31. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262(23):3303-7.
32. Carr-Hill R, Jenkins-Clarke S, Dixon P, Pringle M. Do minutes count? Consultation length in general practice. J Health Serv Res Policy 1998;3(4):207-13.
33. Roter DL, Hall JA. Physician gender and patient-centred communication: a critical review of empirical research. Annu Rev Public Health 2004;25:497-519.
34. Howie JG, Heany DJ, Maxwell M, Walker JJ, Freeman GK, Rai H. Quality of general practice consultations: cross sectional survey. BMJ 1999;319(7212):738- 43. (Pubitemid 29431528)
35. Henriksen K, Hansen EH. The threatened self: general practitioners' selfperception in relation to prescribing medicine. Soc Sci Med 2004;59(1):47-55.
36. Morin CM, Hauri JP, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999;22(8):1134-56.
37. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 2004;164(17):1888-96.
38. Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev 2003;7(3):215-25.
39. Lang AJ. Mental health treatment preferences of primary care patients. J Behav Med 2005;28(6):581-6. Epub 2005 Oct 15.
40. Laine C, Davidoff F, Lewis CE, Nelson EC, Nelson E, Kessler RC, et al. Important elements of outpatient care: a comparison of patients' and physicians' opinions. Ann Intern Med 1996;125(8):640-5. (Pubitemid 126450599)
41. Robbins JA, Bertakis KD, Helms LJ, Azari R, Callanhan EJ, Creten DA. The influence of physician practice behaviours on patient satisfaction. Fam Med 1993;25(1):17-20. (Pubitemid 23049864)
42. Anthierens S. Benzodiazepines: sleeping through the problem. (Avoidance of) initiation of benzodiazepines in primary care, perceptions of general practitioners, patients and nurses [doctoral thesis]. Ghent, Belgium: Ghent University; 2008.
43. Brody DS, Kaliq AA, Thompson TL 2nd. Patients' perspectives on the management of emotional distress in primary care settings. J Gen Intern Med 1997;12(7):403-6.
44. Britten N, Ukoumunne O. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. BMJ 1997;315(7121):1506-10.
45. Bradley CP. Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. Br J Gen Pract 1992;42(364):454-8.
46. Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ 2000;320(7233):484-8. (Pubitemid 30173122)
47. Barter G, Cormack M. The long-term use of benzodiazepines: patients' views accounts and experiences. Fam Pract 1996;13(6):491-7.
48. Matthys J, Elwyn G, van Nuland M, Van Maele G, De Sutter A, De Meyere M, et al. Patients' ideas, concerns, and expectations (ICE) in general practice: impact on prescribing. Br J Gen Pract 2009;59(558):29-36.
49. Sleath B, Svarstad B, Roter D. Physicians versus patient initiation of psychotropic prescribing in primary care settings: a content analysis of audiotapes. Soc Sci Med 1997;44(4):541-8. (Pubitemid 27033836)
50. Denig P, Haaijer-Ruskamp M, Zijsling D. How physicians choose drugs. Soc Sci Med 1988;27(12):1381-6.
51. Boerma WG, Verhaak PF. The general practitioner as the first contacted health professional by patients with psychosocial problems: a European study. Psychol Med 1999;29(3):689-96.
52. Winefield HR, Murell TG, Clifford JV, Farmer EA. The usefulness of distinguishing different types of general practice consultation, or are needed skills always the same? Fam Pract 1995;12(4):402-7.
53. Astin JA, Soeken K, Sierpina VS, Clarridge BR. Barriers to the integration of psychosocial factors in medicine: results of a national survey of physicians. J Am Board Fam Med 2006;19(6):557-65.
54. Deveugele M, Derese A, van den Brink-Muinen A, Bensing J, De Maeseneer J. Consultation length in general practice: cross sectional study in six European countries. BMJ 2002;325(7362):472-7.
55. Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health 2005;27(3):281-91.
56. Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grégoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003;169(10):1015-20. (Pubitemid 37449350)
57. Vicens C, Fiol F, Llobera J, Campoamor F, Mateu C, Alegret S, et al. Withdrawal from long-term benzodiazepine use: randomized trial in family practice. Br J Gen Pract 2006;56(533):958-63.
58. Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD Young R. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction 2009;104(1):13-24. Epub 2009 Oct 31.
59. Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs 2009;23(1):19-34. DOI: 10.2165/0023210-200923010-00002.